Regen Report https://validator.w3.org/feed/docs/rss2.html Homepage Kangstem Publishes Promising Phase 1 Results for Cord-Blood Derived Stem Cell Therapy in Knee Osteoarthritis, Post-MRI Data Suggest Potential Cartilage Regeneration Specialised Therapeutics Nabs Australian Approval For Chronic Graft-Versus-Host Disease Therapy In Patients Receiving Blood Stem Cells Cellenkos To Begin Phase 2 Cord Blood-Derived Treg Trial for Aplastic Anemia Catalent to Supply Cartherics With iPSC Line To Manufacture CAR-NK Cell Therapies In Expanded Agreement Innovacell Seeks $92M in Tokyo IPO to Advance Stem Cell Therapy Development Miracell Receives FDA 510(k) Clearance for SMART M-CELL PRP Concentration System and SMART M-CELL Bone Marrow Concentration System FibroBiologics Studying Fibroblast Treatment for Hantavirus Sana Biotechnology and Mayo Clinic Partner Up on Type 1 Diabetes Stem Cell-Derived Therapy, Phase 1 Potentially This Year BioStem Technologies Receives 5 Patents for Placental Allografts MEDIPOST Calls On Charles River Laboratories To Help Scale GMP-Compliant Stem Cell Therapy Royal Biologics and Jellagen Bringing Jellyfish-Derived Collagen Type Zero to the US Regenerative Medicine Market Dark Horse Consulting Group and KunTuo Team Up To Accelerate Cell & Gene Therapy Trials In China First Lupus Patients Dosed With Cabaletta Bio’s Rese-Cel, Manufactured on Cellares’ Automated Cell Shuttle Platform Thermo Fisher Scientific Unveils an Integrated Platform to Advance Scalable Cell Therapy Manufacturing Cord for Life Completes Dosing of First Clinical Trial Using Cord Blood Stem Cells for Lower Back Pain Trailhead Biosystems Expands iPSC-Derived Cell Portfolio With TrailBio Endothelial Cells Latus Bio Nabs $97 Million to Continue Neurodegenerative Gene Therapy Pipeline Immatics Testing Cellular Origins’ Automated Cell Therapy Manufacturing Platform for Immuno-Oncology Programs Interview: siRNA-Loaded Stem Cell Exosomes, Inside NurExone Biologic’s Spinal Cord Injury Candidate Mesoblast’s Phase 3 Stem Cell for Lower Back Pain Trial Achieves Patient Recruitment, Results Expected Mid-2027 Cellular Intelligence, Backed by Zuckerberg, Acquires Novo Nordisk’s Parkinson’s Cell Therapy Tech Colorado Boulder’s Injection Shows Promise for Reversing Osteoarthritis, Advancing ARPA-H Project Phase II Finds Umbilical Cord Blood Transplant With Pooled Stem Cell Product Shows 96% Survival and No Graft-Versus-Host Disease in Leukemia Patients MEDIPOST’s Umbilical Cord Stem Cell Phase 3 For Knee Osteoarthritis Meets Primary Endpoints In Japan, Setting Up Commercialization Novartis Receives Positive CHMP Opinion for its Gene Therapy, Itvisma, for Spinal Muscular Atrophy Scripps Health Receives $12.7 Million Grant for Stem Cell Knee Research Regeneron Nabs Deal with White House, New Gene Therapy Will Be Free Mesoblast Acquires Mayo Clinic’s Chimeric Antigen Receptor (CAR) Platform to Enhance its Stem Cell Therapies NurExone Biologic’s U.S. Subsidiary Exo-Top and BioXtek Sign LOI to Partner On Exosome Manufacturing and Commercialization Q&A – Inside iDEM, Mytos’ Automated Cell Therapy Manufacturing Platform Interview: Veterinary Stem Cells – Gallant’s Quest for the First FDA-Approved MSC Therapy Orthocell Secures US Department of Defense Approval for Remplir Collagen Nerve Wrap Dark Horse Consulting Acquires Bruder Consulting, Launches New Regenerative Medicine Division TBMC Opens GMP Facility in Zhubei, Taiwan for Cell, Gene, and mRNA Manufacturing XellSmart Launches iPSC Phase II for Parkinson’s Following Encouraging Phase I Results Xintela Granted U.S. Patent for XSTEM Treatment of Difficult-to-Heal Wounds and Skin Defects Indiana University Opens New Stem Cell Research Center for Alzheimer’s and Dementias New Korean Stem Cell Hub Coming to Baltimore, Focused on OA and Alzheimer’s Research AAOS Launches New Orthobiologics Registry to Improve Knee Osteoarthritis Research Gallant Reports Positive Pilot Data for Feline Osteoarthritis Stem Cell Therapy; Receives FDA Eligibility for Expanded Conditional Approval Pathway Korea Launches First Clinical-Grade iPSC Distribution for Research and Therapeutics Development Medipost to Launch Phase 3 of CARTISTEM, its Cord Blood Stem Cell Therapy, for Knee Osteoarthritis Bracco Enters Cell Therapy Manufacturing with Cell Selection and Activation Technologies Arizona Pushes New Stem Cell Therapy Bill Longeveron Granted Chinese Patent for Potency Assay Methods for Assessing Human Mesenchymal Stem Cells HexemBio Emerges from Stealth Mode with $10.4 Million Raised for Blood Stem Cell Rejuvenation Therapy Development Bracco Upgrading its Cell Therapy Manufacturing Plant for 2027 Production New Startup iOrganBio Launches with $2M for AI-Based Cell Manufacturing Platform, CellForge™ Proposed Stem Cell Class Action: “QC Kinetix Illegally Fails to Disclose Lack of FDA Approval of ‘Worthless’ Stem Cell, Regenerative Treatments in Florida”